Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature
- PMID: 20038527
- PMCID: PMC4301611
- DOI: 10.1177/0883073809341669
Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature
Abstract
Metachromatic leukodystrophy is a rare disorder with great clinical variability. We report the first case of triplets with the late infantile form of the disease and their systematic progression of symptoms. We reviewed the literature and identified all human studies that reported new cases since 1921. We analyzed survival by decade to assess the impact of historical changes in the management of care. Mean age at death and the 5-year survival from onset of symptoms for late infantile, juvenile, and adult phenotypes were 4.2 years and 24.9%, 17.4 years and 70.3%, and 43.1 years and 88.6%, respectively. The 5-year survival of cases reported after 1990 was significantly better than cases reported before 1970 in all subtypes of metachromatic leukodystrophy (late infantile: 52% vs 14%, juvenile: 100% vs 46%, adult: 95% vs 67%). Survival in the late infantile subtype was worse than that in other subtypes. Survival significantly improved over time in all subtypes.
Conflict of interest statement
The authors have no conflicts of interest.
Figures



Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
-
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079. Health Technol Assess. 2024. PMID: 39046101 Free PMC article.
Cited by
-
Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers.Orphanet J Rare Dis. 2019 Apr 29;14(1):89. doi: 10.1186/s13023-019-1060-2. Orphanet J Rare Dis. 2019. PMID: 31036045 Free PMC article.
-
Myelin lipid metabolism and its role in myelination and myelin maintenance.Innovation (Camb). 2022 Dec 7;4(1):100360. doi: 10.1016/j.xinn.2022.100360. eCollection 2023 Jan 30. Innovation (Camb). 2022. PMID: 36588745 Free PMC article. Review.
-
Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases.Int J Mol Sci. 2020 Aug 25;21(17):6113. doi: 10.3390/ijms21176113. Int J Mol Sci. 2020. PMID: 32854299 Free PMC article. Review.
-
Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.Orphanet J Rare Dis. 2015 Aug 7;10:94. doi: 10.1186/s13023-015-0313-y. Orphanet J Rare Dis. 2015. PMID: 26245762 Free PMC article.
-
Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy.Orphanet J Rare Dis. 2022 Oct 4;17(1):370. doi: 10.1186/s13023-022-02518-z. Orphanet J Rare Dis. 2022. PMID: 36195888 Free PMC article.
References
-
- von-Figura KGV, Jaeken J. Metachromatic Leukodystrophy. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The Metabolic & Molecular Bases of Inherited Disease. 8 ed. McGraw-Hill: 2001. pp. 3695–3724.
-
- Percy AMG. The Biochemistry of Myelin and Leukodystrophies. In: Vinken PBG, editor. Handbook of Clinical Neurology. Amsterdam: North Holland Publishing Co; 1970. pp. 3695–3724.
-
- Witte F. Ueber pathologische Abbauvorgange im Zentralnervensystem. Munch. Med. Wochenschr. 1921;68:69.
-
- Austin JH. Metachromatic form of diffuse cerebral sclerosis. I. Diagnosis during life by urine sediment examination. Neurology. 1957;7(6):415–426. - PubMed
-
- Austin J. Recent Studies in the Metachromatic and Globoid Body Forms of diffuse Sclerosis. In: Folch-Pi JAB H, editor. Brain Lipids and Lipoproteins and Leucodystrophies. 1st ed. New York: Elsevier Publishing Company; 1963.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical